JOHNSON & JOHNSON

(853260)
  Bericht
Verzögert Nyse  -  22:00 24.06.2022
182.29 USD   +1.46%
24.06.Janssen von Johnson & Johnson erhält Unterstützung des Gremiums der EU-Arzneimittelagentur für Leukämiemedikamente
MT
24.06.Johnson & Johnson's Unit Janssen sagt, dass der EMA-Ausschuss die Zulassung von Imbruvica zur Behandlung von chronischer lymphatischer Leukämie unterstützt
MT
22.06.JOHNSON & JOHNSON : erhält Kaufen-Rating von Daiwa Securities
MM
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über JOHNSON & JOHNSON
24.06.Johnson & Johnson's Janssen Receives EU Medicines Agency Panel's Backing for Leukemia D..
24.06.J&J : avis favorable de l'UE pour un anti-leucémique
24.06.Johnson & Johnson's Unit Janssen Says EMA's Committee Backs Approval of Imbruvica to Tr..
24.06.JOHNSON & JOHNSON'S JANSSEN : CHMP Backs Expanded Imbruvica Use in Chronic Lymphocytic Leu..
24.06.J&J : confirme son engagement contre les maladies tropicales
23.06.JOHNSON & JOHNSON : Renews Commitment to Fight Neglected Tropical Diseases, Investing in B..
22.06.Powell's tall order to reassure investors
22.06.ANALYST RECOMMENDATIONS : Johnson & Johnson, NatWest, Home Depot, Kraft Heinz, Vodafone...
21.06.Le roi des céréales Kellogg annonce sa scission en trois entreprises
21.06.TRANSCRIPT : Johnson & Johnson - Special Call
21.06.Johnson & Johnson Opens Asia-Pacific Satellite Center for Global Health Discovery in Si..
21.06.Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Paci..
21.06.Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Paci..
18.06.AFRIQUE DU SUD : une "bataille difficile" remportée avec la levée des brevets
17.06.Standard & Poor's 500 Enters Bear Market Territory as Fed Pivot to Price Stability Fuel..
16.06.Wall Street finit en forte baisse, craint que la Fed n'ait la main trop lourde
16.06.TRANSCRIPT : Johnson & Johnson Presents at Goldman Sachs 43rd Annual Global Healthcare Con..
16.06.Federal Government Removes Vaccination Requirements For Domestic And Out-Bound Travel
15.06.Top Local Changemakers Addressing Health Equity Gaps Across the U.S. Named Johnson & Jo..
15.06.Evotec enters a drug discovery collaboration with Janssen
15.06.JOHNSON & JOHNSON VISION ON TRACK FO : ACUVUE® OASYS MAX 1-Day
15.06.INSIDER SELL : Johnson & Johnson
14.06.Evotec, Johnson & Johnson's Unit Janssen Partner to Discover New Drug Candidates
13.06.Valneva risque de ne pas fournir son vaccin à l'Europe
10.06.Johnson & Johnson Unit Janssen Says Early Trial Data Shows Positive Results for Teclist..
10.06.JOHNSON & JOHNSON : New IMBRUVICA® (ibrutinib) Data in Fixed-Duration Combination Regimen ..
10.06.JOHNSON & JOHNSON : Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bisp..
10.06.Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
10.06.Genmab Seeks $405 Million in New Arbitration With Janssen
10.06.Genmab Opens New Arbitration In Daratumumab License Dispute With Janssen
08.06.COVID-19 VACCINES : No Sharing Of Know-How
08.06.Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ..
08.06.Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA (erdafitinib..
08.06.Royal Philips - Willem Appelo to succeed Sophie Bechu as Philips Chief Operations Offic..
07.06.Johnson & Johnson Unit Janssen Says Initial Data From Phase 2 Trial of Balversa Shows R..
07.06.Philips Names Willem Appelo COO
06.06.Emergent Biosolutions Claims Janssen Pharmaceuticals Breached COVID-19 Vaccine Producti..
06.06.SECTOR UPDATE : Health Care Stocks Slip Amid Losses for Biotechs
06.06.Emergent Biosolutions Claims Janssen Pharmaceuticals Breached COVID-19 Vaccine Producti..
06.06.SECTOR UPDATE : Health Care Stocks Edging Higher This Afternoon
06.06.SECTOR UPDATE : Health Care
06.06.US Stocks Weakening in Midday Trading but Largely Staying on Positive Ground
06.06.Top Midday Gainers
06.06.Yumanity Therapeutics Shares Soar on Kineta Deal
06.06.J&J Risks Up to $420 Million Liability as Emergent Claims COVID-19 Jab Contract Breach
06.06.Wall Street Set for Gains, China Tech ADRs Rise on Signs of Easing Regulatory Pressure
06.06.J&J : résultats encourageants dans le myélome multiple
06.06.Emergent BioSolutions Says Janssen Has Breached Covid Vaccine Contract
06.06.The Janssen Pharmaceutical - Phase 3 SHINE Results Show IMBRUVICA (ibrutinib)-Based Com..
06.06.The Janssen Pharmaceutical Companies - Longer-term Data from CARTITUDE-1 Study Demonstr..
06.06.The Janssen Pharmaceutical Companies - Updated Data for Janssen's Bispecific Teclistama..
06.06.Top Premarket Gainers
06.06.Yumanity to Sell Neurosciences Candidates, Merge With Kineta
06.06.J&J : données mises à jour sur le teclistamab
06.06.JOHNSON & JOHNSON : ETHICON LAUNCHES NEXT GENERATION ECHELON™ 3000 STAPLER DESIGNED ..
06.06.Johnson & Johnson agreed to acquire Assets of Wholesale Brokerage & Binding and Managin..
05.06.JOHNSON & JOHNSON : Longer-term Data from CARTITUDE-1 Study Demonstrate Continued Deep and..
03.06.Johnson & Johnson's Imbruvica Meets Target in Late-Stage Mantle Cell Lymphoma Trial in ..
03.06.JOHNSON & JOHNSON : Phase 3 SHINE Results Show IMBRUVICA® (ibrutinib)-Based Combination Re..
02.06.Bristol Myers, J&J Arthritis Drugs Cut Covid-19 Deaths in NIH Study
02.06.The Janssen Pharmaceutical - New Data Show Patients Treated with First-in-Class TREMFYA..
01.06.J&J : nouvelles données positives autour du Tremfya
01.06.TRANSCRIPT : Johnson & Johnson Presents at Bernstein 38th Annual Strategic Decisions Confe..
01.06.JOHNSON & JOHNSON : New Data Show Patients Treated with First-in-Class TREMFYA® (guselkuma..
01.06.WEIZMANN INSTITUTE OF SCIENCE : Changing the Channel: Study Sheds New Light on a Promising..
01.06.Johnson & Johnson Unit Says Psoriatic Arthritis Drug Showed Sustained Efficacy in Phase..
01.06.John Wood va vendre sa division de conseil en environnement bâti pour 1,9 Mds$
01.06.ViiV Healthcare announces marketing approval by Japan's Ministry of Health, Labour and ..
31.05.INSIDER SELL : Johnson & Johnson
31.05.JOHNSON & JOHNSON : Janssen to Highlight Science, Innovation and Advances in Robust Oncolo..
31.05.GSK's ViiV Healthcare Secures Japanese Marketing Approval for HIV Treatment Vocabria
29.05.Main events scheduled for Monday, May 30
26.05.Legend Biotech Receives Conditional European Commission Approval for Multiple Myeloma D..
25.05.JOHNSON & JOHNSON : to Provide Webcast Fireside Chat on Clinical Data to be Presented at t..
25.05.Tentative $161.5M settlement reached in WVa opioid trial
1  2  3  4  5  6  7  8  9  10Weiter